Sylwia Lapinska-Szumczyk
Overview
Explore the profile of Sylwia Lapinska-Szumczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jopek M, Jopek M, Sieczczynski M, Pastuszak K, Lapinska-Szumczyk S, Jassem J, et al.
Blood Adv
. 2024 Dec;
9(5):979-989.
PMID: 39715465
Ovarian cancer (OC) presents a diagnostic challenge, often resulting in poor patient outcomes. Platelet RNA sequencing, which reflects host response to disease, shows promise for earlier OC detection. This study...
2.
Wenta R, Richert J, Muchlinska A, Senkus E, Suchodolska G, Lapinska-Szumczyk S, et al.
Cytometry A
. 2024 Nov;
105(12):883-892.
PMID: 39498617
Liquid biopsies developed into a range of sensitive technologies aiming to analyze for example, circulating tumor cells (CTCs) in peripheral blood, which significantly deepens understanding of the metastatic process. Nevertheless,...
3.
Gao Y, Liu C, Li H, Xiong X, Li G, In t Veld S, et al.
Protein Cell
. 2023 Mar;
14(6):579-590.
PMID: 36905391
Platelets are reprogrammed by cancer via a process called education, which favors cancer development. The transcriptional profile of tumor-educated platelets (TEPs) is skewed and therefore practicable for cancer detection. This...
4.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
5.
Lukasiewicz M, Pastuszak K, Lapinska-Szumczyk S, Rozanski R, In t Veld S, Bienkowski M, et al.
Cancers (Basel)
. 2021 Nov;
13(22).
PMID: 34830891
Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this...
6.
Pastuszak K, Supernat A, Best M, In t Veld S, Lapinska-Szumczyk S, Lojkowska A, et al.
Mol Oncol
. 2021 May;
15(10):2688-2701.
PMID: 34013585
Liquid biopsies offer a minimally invasive sample collection, outperforming traditional biopsies employed for cancer evaluation. The widely used material is blood, which is the source of tumor-educated platelets. Here, we...
7.
Smolle M, Czapiewski P, Lapinska-Szumczyk S, Majewska H, Supernat A, Zaczek A, et al.
Int J Mol Sci
. 2019 Dec;
20(24).
PMID: 31817792
Whilst the role of eukaryotic translation initiation factors (eIFs) has already been investigated in several human cancers, their role in endometrial cancer (EC) is relatively unknown. In the present retrospective...
8.
Luczak A, Supernat A, Lapinska-Szumczyk S, Jachimowicz D, Majewska H, Gulczynski J, et al.
Int J Biol Markers
. 2016 Feb;
31(3):e245-51.
PMID: 26868332
Background: Endometrial cancer (EC) is a hormone-related disease, showing highly diverse features of ER/PR/HER2 status-based molecular subtypes. Long noncoding RNA (lncRNA) HOX antisense intergenic RNA (HOTAIR) has recently emerged as...
9.
Lapinska-Szumczyk S, Supernat A, Zaczek A, Majewska H, Gulczynski J, Sawicki S, et al.
Ginekol Pol
. 2014 Dec;
85(10):754-9.
PMID: 25546926
Objectives: The aim the study was to compare two groups of endometrial cancer patients (below and above 45 years of age) in the aspect of clinicopathological and molecular data. Material...
10.
Lapinska-Szumczyk S, Supernat A, Majewska H, Gulczynski J, Luczak A, Biernat W, et al.
Clin Transl Sci
. 2014 Sep;
7(6):482-8.
PMID: 25201050
Endometrial cancer (EC) is a hormone-dependent, most frequent malignancy of the female genital tract, yet no molecular subtype classification based receptor status (estrogen receptor [ER], progesterone receptor [PR], human epidermal...